PDCD1 and neoplasm: In order to determine whether the anti-tumor effect of chloroquine and PD-1 siRNA combined therapy is due to the activation of systemic tumor-specific cellular immunity, we isolated T lymphocytes from mouse spleen cells of all groups, respectively.